A prospective natural history study protocol for clinical trial readiness in synaptic disorders
Epilepsia · 2026-10 · 67 (10) · 5448-5463
DOI: 10.1002/epi.70374 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Epilepsia, online erschienen am 14.07.2026. Verfasst von Jillian L McKee und 38 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Munc18 Proteins, Epilepsy, Developmental Disabilities, ras GTPase-Activating Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Pediatric Epilepsy Research Foundation, Warren Alpert Foundation.
Abstract (Originalsprache)
Objective
STXBP1‐ related disorder ( STXBP1 ‐RD) and SYNGAP1 ‐related disorder ( SYNGAP1 ‐RD) are two common genetic synaptopathies that are associated with epilepsy, developmental delay, intellectual developmental disorder, and behavioral problems. Both STXBP1 ‐RD and SYNGAP1 ‐RD are potential targets for disease‐modifying therapies, but there is limited information in the literature describing the natural history of either disorder, which impedes outcome selection for future clinical trials. The objective of this study is to develop a framework to better define and outline the clinical spectrum and longitudinal trajectories of STXBP1 ‐RD and SYNGAP1 ‐RD natural history, including development, behavior, seizure histories, and electrophysiology.
Methods
Here, we describe a protocol, regulatory structure, and supportive preliminary data for multicenter, prospective natural history studies of STXBP1 ‐RD (STARR) and SYNGAP1 ‐RD (ProMMiS). The protocols incorporate gold standard clinician‐administered outcome measures including the Bayley Scales of Infant and Toddler Development 4th edition, Gross Motor Function Measure‐66, fine motor domains of the Peabody Developmental Motor Scales 3rd edition, parent‐reported outcome measures, epilepsy histories, and biomarker exploration. To date, the study has enrolled 164 individuals with STXBP1 ‐RD and 159 with SYNGAP1 ‐RD, with ongoing longitudinal assessments every 6 months in a subset of approximately 200 total individuals across both disorders.
Results
Our data support that existing developmental measures are feasible, informative, and show minimal floor or ceiling effects. Furthermore, we demonstrate that medical record‐based seizure history reconstruction reveals unique epilepsy trajectories while minimizing burden to families. We observe disease‐specific patterns of developmental performance and distinct longitudinal seizure dynamics, highlighting the need for data generation in a gene/disorder‐specific manner for clinical trial readiness. Significance In summary, we present a feasible natural history protocol with prospective data for two complex neurodevelopmental disorders with natural histories that have previously been incompletely characterized, within a regulatory framework that will support the use of these data to expedite clinical trial development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Epilepsy NeuroGenetics Initiative, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Center for Epilepsy and NeuroDevelopmental Disorders, CHOP/Penn, Philadelphia, Pennsylvania, USA.
- Division of Developmental and Behavioral Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Jillian L McKee, Sarah M Ruggiero, Kristin Cunningham, Ian McSalley, Michael C Kaufman, Bintou Bane, Jonathan Toib, Sarah Tefft, Julie M Orlando, Alexander K Gonzalez, Johanna Mercurio, Jan H Magielski, Zachary Grinspan, Megan Abbott, Juliet Knowles, Hsiao-Tuan Chao, Katherine Xiong, Elizabeth Berry-Kravis, Sepideh Tabarestani, J Michael Graglia, Kathryn Helde, Charlene Son Rigby, James Goss, Scott Demarest, Benjamin Prosser, Michael J Boland, Samuel R Pierce, Ingo Helbig
Förderung
- NINDS NIH HHS
- Pediatric Epilepsy Research Foundation
- Warren Alpert Foundation
- STXBP1 Foundation
- American Brain Foundation
- CURE SYNGAP1
- American Academy of Neurology
- Center for Epilepsy and Neurodevelopmental Disorders
Zitieren
APA
McKee, J. L., Ruggiero, S. M., Cunningham, K., Coyne, J., McSalley, I., Kaufman, M. C., Bane, B., Chisari, T., Toib, J., Glatts, C., Tefft, S., Orlando, J. M., Padmanabhan, V., Gonzalez, A. K., Harrison, A., Woo, C., Zbikowski, S. A., Dhaduk, R., Mercurio, J., …, & Helbig, I. (2026). A prospective natural history study protocol for clinical trial readiness in synaptic disorders. Epilepsia, 67(10), 5448-5463. https://doi.org/10.1002/epi.70374
Vancouver
McKee JL, Ruggiero SM, Cunningham K, Coyne J, McSalley I, Kaufman MC, et al. A prospective natural history study protocol for clinical trial readiness in synaptic disorders. Epilepsia. 2026;67(10):5448-5463. doi:10.1002/epi.70374
BibTeX
@article{McKee2026,
author = {McKee, Jillian L and Ruggiero, Sarah M and Cunningham, Kristin and Coyne, JoeyLynn and McSalley, Ian and Kaufman, Michael C and Bane, Bintou and Chisari, Torrey and Toib, Jonathan and Glatts, Carlyn and Tefft, Sarah and Orlando, Julie M and Padmanabhan, Viveknarayanan and Gonzalez, Alexander K and Harrison, Alicia and Woo, Charlene and Zbikowski, Stephanie A and Dhaduk, Rency and Mercurio, Johanna and McCarthy, Macie and Magielski, Jan H and Grinspan, Zachary and Abbott, Megan and Knowles, Juliet and Chao, Hsiao-Tuan and Xiong, Katherine and Berry-Kravis, Elizabeth and Tabarestani, Sepideh and Graglia, J Michael and Helde, Kathryn and McNamar, Virginie and Son Rigby, Charlene and Goss, James and Demarest, Scott and Miele, Andrea and Prosser, Benjamin and Boland, Michael J and Pierce, Samuel R and Helbig, Ingo},
title = {A prospective natural history study protocol for clinical trial readiness in synaptic disorders},
journal = {Epilepsia},
year = {2026},
volume = {67},
number = {10},
pages = {5448--5463},
doi = {10.1002/epi.70374}
}
EUVIMED